AAV-DJ/8 Helper Free Expression System
Product details
- Name: AAV-DJ/8 Helper Free Expression System
- Size: 1 test kit
- Catalog no: VPK-410-DJ-8
- Price: 1383 €
Extended information
- This reagent is purified: 0.97
- The temperatureerature for storage is: -20ºC
- Species compatible to: Humans
- We send this reagant on: Blue Ice
- Use of this test kit or product: Genetics lab
- Living modified organisme in this reagent or LMO: Not applicable
- Type of reagent: Viral Expression
- Molecular weight: in kilo Danlto or kDa
- Antigen: a specific protein sequence
- Additional lab advice: Cloning capacity of expression vector = 3 kb
- Buffer: The concentration in mg/ml in a 10mM of buffered solution at pH 7 to 7,94
- Cellular use: Complete Expression System contains packaging plasmids, expression vector and GFP control vector
- Protocol information: pHelper plasmid contains required E2A, E4, and VA RNA adenoviral genes; eliminates the need for a helper adenovirus
- Reagent properties: AAV-DJ/8 is a mutant of AAV-DJ designed to provide increased uptake in brain tissue, closely mimicking AAV-8 and AAV-9
- SDS or safty data sheet: (VPK-410 through VPK-430-SER6) GHS.pdf
- Related techniques: Viral Expression, Adeno-Associated Virus (AAV) Expression, AAV Helper Free Complete Expression Systems, AAV-DJ/8 Helper Free Complete Expression Systems
- Use of the reagent: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. AAV-DJ/8 was created by making a point mutation in the heparin binding domain of AAV-DJ. Recombinant AAV produced from the AAV-DJ/8 system closely resembles AAV-8 and AAV-9 in its ability to infect heart and brain tissues.